These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3791605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.
    Ducas J, Girling L, Schick U, Prewitt RM.
    Circulation; 1986 May; 73(5):1050-7. PubMed ID: 3698227
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC, McLean R, Rosenthal MH, Pearl RG.
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M, Ishii Y, Kitamura S, Ohno S.
    Respiration; 1998 Jan; 65(1):63-70. PubMed ID: 9523370
    [Abstract] [Full Text] [Related]

  • 12. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
    Delcroix M, Mélot C, Lejeune P, Leeman M, Naeije R.
    Anesthesiology; 1990 Jan; 72(1):77-84. PubMed ID: 2297136
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
    Prewitt RM, Downes AM, Gu SA, Chan SM, Ducas J.
    Chest; 1991 Mar; 99(3):708-14. PubMed ID: 1899825
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1.
    Crombleholme TM, Adzick NS, Longaker MT, Bradley SM, Duncan BW, Jennings R, Verrier ED, Harrison MR.
    J Pediatr Surg; 1990 Aug; 25(8):861-6. PubMed ID: 2401941
    [Abstract] [Full Text] [Related]

  • 17. Effects of progressive vascular occlusion on slope and intercept of the pulmonary artery pressure-flow relationship.
    Gu S, Prewitt RM, Schick U, Ducas J.
    Angiology; 1995 Jan; 46(1):45-52. PubMed ID: 7818156
    [Abstract] [Full Text] [Related]

  • 18. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.
    Prewitt RM, Shiffman F, Greenberg D, Cook R, Ducas J.
    Circulation; 1989 Apr; 79(4):929-38. PubMed ID: 2494007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pulmonary vascular effects of dopamine, dobutamine, and isoproterenol in unilobar pulmonary edema in dogs.
    Light RB, Ali J, Breen P, Wood LD.
    J Surg Res; 1988 Jan; 44(1):26-35. PubMed ID: 3336208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.